OOIR: Observatory of International Research

Papers

(The median citation count of Cellular & Molecular Immunology is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
From blood to tissue: take a deeper look at B cells in lupus	894
MHC class II in renal tubules plays an essential role in renal fibrosis	371
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron	364
Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins	294
Remote hyperinflammation drives neurological disease via T-cell-mediated innate-like cytotoxicity	250
No crossreactivity of anti-SARS-CoV-2 spike protein antibodies with Syncytin-1	187
IL-33 in COVID-19: friend or foe?	161
Systems-based approaches to study immunometabolism	158
CAR-T cell therapy: new hope for systemic lupus erythematosus patients	153
Fludarabine inhibits type I interferon-induced expression of the SARS-CoV-2 receptor angiotensin-converting enzyme 2	147
New aspects of HSC mobilization for better therapeutic outcomes	141
SRSF1 plays a critical role in invariant natural killer T cell development and function	106
RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor	105
Immune regulation in the tumor microenvironment and its relevance in cancer therapy	105
Compartmentalized immune responses and the local microbiota determine mucosal and systemic immunity against SARS-CoV-2	104
Group 2 innate lymphoid cells can engulf and destroy bacteria	99
Granulocyte-macrophage colony-stimulating factor: an immunotarget for sepsis and COVID-19	99
SARS-CoV-2 interaction with Siglec-1 mediates trans-infection by dendritic cells	98
Reprogramming cholesterol metabolism in macrophages and its role in host defense against cholesterol-dependent cytolysins	95
NLRP3 inflammasome activation and cell death	93
The CXCR3alt-CXCL11 axis in bladder cancer: potential for prediction of neoadjuvant chemotherapy response	92
FNDC4 and FNDC5 reduce SARS-CoV-2 entry points and spike glycoprotein S1-induced pyroptosis, apoptosis, and necroptosis in human adipocytes	91
CD28 costimulation promotes an antitumor CD8+ T cell response in myeloid antigen-presenting cell niches	81
Restoration of established systemic inflammation and autoimmunity by Foxp3+ regulatory T cells	75
Resident and migratory adipose immune cells control systemic metabolism and thermogenesis	74

Altered expression of glymphatic system-related proteins in prion diseases: Implications for the role of the glymphatic system in prion diseases	74
Continuous activation of polymorphonuclear myeloid-derived suppressor cells during pregnancy is critical for fetal development	74
ENO1 promotes antitumor immunity by destabilizing PD-L1 in NSCLC	73
Screening HLA-A-restricted T cell epitopes of SARS-CoV-2 and the induction of CD8+ T cell responses in HLA-A transgenic mice	70
Significantly reduced abilities to cross-neutralize SARS-CoV-2 variants by sera from convalescent COVID-19 patients infected by Delta or early strains	68
The spike protein of SARS-CoV-2 variant A.30 is heavily mutated and evades vaccine-induced antibodies with high efficiency	66
Diet, lipids, and antitumor immunity	65
The use of supercytokines, immunocytokines, engager cytokines, and other synthetic cytokines in immunotherapy	64
Publisher Correction: Epitopes for a 2019-nCoV vaccine	54
Correction: Single-cell profiling reveals the trajectories of natural killer cell differentiation in bone marrow and a stress signature induced by acute myeloid leukemia	54
Ripping the Ripoptosome: a novel path for blocking allergic inflammation?	51
New insights into follicular helper T cell response and regulation in autoimmune pathogenesis	48
Reversing the mitochondrial stress-induced exhaustion of CD8+ T cells for improving cancer immunotherapy	48
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells	48
Protein synthesis, degradation, and energy metabolism in T cell immunity	47
Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor	45
Mitochondrial-triggered immune responses mechanistically connect drug-induced steatohepatitis and cardiomyopathy associated with nonalcoholic steatohepatitis	44
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy	43
Analysis of uterine CD49a+ NK cell subsets in menstrual blood reflects endometrial status and association with recurrent spontaneous abortion	42
The complex role of PD-L1 in antitumor immunity: a recent update	41
Optimal model establishment of whole-process management data for CAR-T therapy in China—how should this be done?	40
Correction: Autophagy receptor CCDC50 modulates STING-mediated interferon response in viral infection and autoimmune disease	40
Distinct roles but cooperative effect of TLR3/9 agonists and PD-1 blockade in converting the immunotolerant microenvironment of irreversible electroporation-ablated tumors	38
The circular RNA circINPP4B acts as a sponge of miR-30a to regulate Th17 cell differentiation during progression of experimental autoimmune encephalomyelitis	38
Kupffer cell restoration after partial hepatectomy is mainly driven by local cell proliferation in IL-6-dependent autocrine and paracrine manners	37
The blood–brain barrier in systemic infection and inflammation	37
Dynamic regulation of innate lymphoid cells in the mucosal immune system	37
Aberrant cytokine milieu and signaling affect immune cell phenotypes and functions in tuberculosis pathology: What can we learn from this phenomenon for application to inflammatory syndromes?	36
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection	35
Microenvironmental influences on T cell immunity in cancer and inflammation	34
Activation of AMPKα1 is essential for regulatory T cell function and autoimmune liver disease prevention	32
A new perspective is needed for positive selection of germinal center B cells with higher-affinity B cell receptors	32
Metabolism of tissue macrophages in homeostasis and pathology	32
Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model	31
Biology and pathology of the uterine microenvironment and its natural killer cells	30
Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors	28
Metabolic programming in dendritic cells tailors immune responses and homeostasis	28
Construction of a sustainable 3-hydroxybutyrate-producing probiotic Escherichia coli for treatment of colitis	26
No evidence for increased cell entry or antibody evasion by Delta sublineage AY.4.2	25
SARS-CoV-2-specific T cells in infection and vaccination	25
Yeast display of MHC-II enables rapid identification of peptide ligands from protein antigens (RIPPA)	25
Cross-reactive antibody immunity against SARS-CoV-2 in children and adults	22
The hepatic macrophage pool in NASH	22
c-Met enforces proinflammatory and migratory features of human activated CD4+ T cells	22
Priming of NLRP3 inflammasome activation by Msn kinase MINK1 in macrophages	22
Retraction Note: Trans-silencing effect of the 3′RR immunoglobulin heavy chain enhancer on Igκ transcription at the pro-B cell stage	22
HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance	21
Retraction Note: 3′RR and 5′Eμ immunoglobulin heavy chain enhancers are independent engines of locus remodeling	21
NK cell dysfunction in patients with COVID-19	21